Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BBNX Beta Bionics	$17.89 +0.6%	$14.65	$8.89 ▼ $24.50	$775.64M	N/A	483,453 shs	367,321 shs
KIDS OrthoPediatrics	$20.29 +0.7%	$21.35	$19.52 ▼ $35.99	$492.78M	1.08	200,269 shs	138,889 shs
LUCD Lucid Diagnostics	$1.26	$1.28	$0.71 ▼ $1.80	$136.32M	1.31	603,797 shs	3.05 million shs
TMCI Treace Medical Concepts	$5.51 +0.9%	$6.38	$4.54 ▼ $10.79	$346.52M	0.68	540,772 shs	438,259 shs

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BBNX Beta Bionics	+0.62%	-6.29%	+14.97%	+18.48%	+1,788,999,900.00%
KIDS OrthoPediatrics	+0.69%	-4.11%	-7.14%	-18.74%	-32.23%
LUCD Lucid Diagnostics	0.00%	-2.33%	-5.26%	-17.11%	+74.54%
TMCI Treace Medical Concepts	+0.92%	-2.82%	-12.40%	-33.21%	-8.62%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BBNX Beta Bionics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	4.216 of 5 stars	3.4	2.0	0.0	3.9	2.6	3.3	0.6
LUCD Lucid Diagnostics	3.4646 of 5 stars	3.6	5.0	0.0	0.0	3.2	1.7	0.6
TMCI Treace Medical Concepts	1.6969 of 5 stars	3.1	1.0	0.0	0.0	0.6	3.3	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BBNX Beta Bionics	2.75	Moderate Buy	$23.44	31.05% Upside
KIDS OrthoPediatrics	2.83	Moderate Buy	$35.83	76.61% Upside
LUCD Lucid Diagnostics	3.20	Buy	$3.55	181.75% Upside
TMCI Treace Medical Concepts	2.29	Hold	$10.16	84.34% Upside

Current Analyst Ratings Breakdown

Latest LUCD, KIDS, BBNX, and TMCI Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/16/2025	BBNX Beta Bionics	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$26.00
6/12/2025	BBNX Beta Bionics	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy ➝ Buy	$30.00
6/6/2025	LUCD Lucid Diagnostics	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$7.50 ➝ $7.75
5/30/2025	BBNX Beta Bionics	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral	$16.00
5/30/2025	BBNX Beta Bionics	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$20.00
5/15/2025	LUCD Lucid Diagnostics	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$2.00 ➝ $2.00
5/14/2025	LUCD Lucid Diagnostics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$3.00 ➝ $3.00
5/9/2025	TMCI Treace Medical Concepts	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$10.00 ➝ $8.60
5/8/2025	KIDS OrthoPediatrics	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$40.00 ➝ $30.00
5/8/2025	KIDS OrthoPediatrics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$42.00 ➝ $42.00
4/21/2025	LUCD Lucid Diagnostics	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$7.00 ➝ $7.50

(Data available from 6/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BBNX Beta Bionics	$65.12M	11.91	N/A	N/A	($5.72) per share	-3.13
KIDS OrthoPediatrics	$204.73M	2.41	N/A	N/A	$14.64 per share	1.39
LUCD Lucid Diagnostics	$4.35M	31.34	N/A	N/A	($0.78) per share	-1.62
TMCI Treace Medical Concepts	$209.36M	1.66	N/A	N/A	$1.81 per share	3.04

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BBNX Beta Bionics	-$54.76M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	-$37.82M	-$1.75	N/A	N/A	N/A	-19.15%	-7.03%	-5.45%	8/4/2025 (Estimated)
LUCD Lucid Diagnostics	-$45.53M	-$1.34	N/A	N/A	N/A	-1,699.86%	N/A	-124.27%	8/11/2025 (Estimated)
TMCI Treace Medical Concepts	-$55.74M	-$0.85	N/A	N/A	N/A	-25.14%	-48.69%	-24.59%	8/5/2025 (Estimated)

Latest LUCD, KIDS, BBNX, and TMCI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/8/2025	Q1 2025	TMCI Treace Medical Concepts	-$0.31	-$0.25	+$0.06	-$0.25	$52.07 million	$52.57 million
5/7/2025	Q1 2025	KIDS OrthoPediatrics	-$0.26	-$0.39	-$0.13	-$0.46	$51.68 million	$52.41 million
5/6/2025	Q1 2025	BBNX Beta Bionics	-$0.51	-$0.52	-$0.01	-$0.93	N/A	N/A
3/25/2025	Q4 2024	BBNX Beta Bionics	-$0.42	-$1.82	-$1.40	-$2.72	$20.01 million	$20.44 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BBNX Beta Bionics	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	N/A	N/A	N/A	N/A	N/A
LUCD Lucid Diagnostics	N/A	N/A	N/A	N/A	N/A
TMCI Treace Medical Concepts	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BBNX Beta Bionics	N/A	15.88	14.93
KIDS OrthoPediatrics	0.21	6.19	2.99
LUCD Lucid Diagnostics	N/A	0.75	0.74
TMCI Treace Medical Concepts	0.51	4.50	3.36

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BBNX Beta Bionics	N/A
KIDS OrthoPediatrics	69.05%
LUCD Lucid Diagnostics	74.01%
TMCI Treace Medical Concepts	84.08%

Insider Ownership

Company	Insider Ownership
BBNX Beta Bionics	N/A
KIDS OrthoPediatrics	32.70%
LUCD Lucid Diagnostics	6.80%
TMCI Treace Medical Concepts	27.72%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BBNX Beta Bionics	294	43.36 million	N/A	N/A
KIDS OrthoPediatrics	200	24.29 million	16.35 million	Optionable
LUCD Lucid Diagnostics	70	108.19 million	100.83 million	No Data
TMCI Treace Medical Concepts	250	62.89 million	45.46 million	Optionable

LUCD, KIDS, BBNX, and TMCI Headlines

Recent News About These Companies

Treace Medical Concepts, Inc. (NASDAQ:TMCI) is favoured by institutional owners who hold 53% of the company

June 21 at 7:04 PM | finance.yahoo.com

Brokerages Set Treace Medical Concepts, Inc. (NASDAQ:TMCI) Price Target at $10.16

June 15, 2025 | americanbankingnews.com

Attention Long-Term Treace Medical Concepts, Inc. (™CI) Shareholders: Grabar Law Office is Investigating Claims on Your Behalf

June 13, 2025 | investing.com

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Recommendation of "Hold" by Brokerages

June 12, 2025 | marketbeat.com